PharmiWeb.com - Global Pharma News & Resources

Clinical trials - Press Releases

Date Title Company
24-May-2023 Immutep announces promising new clinical data from triple combination therapy in INSIGHT-003 trial Immutep
24-May-2023 ImmunOs Therapeutics Announces Initiation of Dosing in Phase 1 Trial of Lead Compound IOS-1002 ImmunOs Therapeutics
24-May-2023 Thermosome Announces First Patient Dosed in Phase I Trial with Lead Program THE001 Thermosome GmbH
23-May-2023 Promising Phase 1 results for antibody NI006 in ATTR cardiomyopathy published in The New England Journal of Medicine Neurimmune
23-May-2023 Two thirds of Brits would take part in a clinical trial to help discover new treatments - but financial payment is key Lindus Health
18-May-2023 Kynos Therapeutics announces a first-in-human Phase I study of its novel small molecule KMO inhibitor, KNS366, is underway Kynos Therapeutics
18-May-2023 Primary Results of the Phase 1b Proof-of-Concept Study of NI006 to be presented at the ESC Heart Failure Congress 2023 Neurimmune
16-May-2023 ABBOTT ANNOUNCES NEW PARTNERSHIPS AND PROGRAMS TO ADVANCE ITS DIVERSITY IN CLINICAL TRIALS INITIATIVE ABBOTT
12-May-2023 Nirsevimab delivers 83% reduction in RSV infant hospitalizations in a real-world clinical trial setting Sanofi
12-May-2023 ABBOTT ANNOUNCES NEW PARTNERSHIPS AND PROGRAMS TO ADVANCE ITS DIVERSITY IN CLINICAL TRIALS INITIATIVE Abbott
12-May-2023 England’s first Integrated Pathology Unit focusing on clinical trial research will use novel technology to diagnose cancer faster and more affordably The Institute for Cancer Research, London
11-May-2023 The Karl Landsteiner University of Health Sciences Announces New England Journal of Medicine Shares Phase 3 Trial Data Evaluating Viaskin™ for Peanut-Allergic Toddlers Karl Landsteiner University of Health Sciences
10-May-2023 Impact Shine Communications rolls in to advance Life Science Business and Marketing Strategies Impact Shine Communications Ltd
10-May-2023 Impact Shine Communications rolls in to advance Life Science Business and Marketing Strategies Impact Shine Communications Ltd
10-May-2023 Transgene - First Patient Dosed in Phase I Trial Evaluating TG6050, a Novel IL-12-Armed Oncolytic Virus Administered Intravenously, in Non-Small Cell Lung Cancer Transgene
09-May-2023 ImmunoGen Announces Results from the Phase 3 MIRASOL Trial Selected as Late-Breaking Presentation for ASCO 2023 Annual Meeting ImmunoGen
09-May-2023 Positive Interim Data of BellaSeno’s Clinical Trial with Resorbable Breast and Chest Implants Reported at RACS 2023 BellaSeno GmbH
08-May-2023 Omnix Medical Announces Excellent Topline Data from the Phase I Clinical Trial of its Novel Anti-Infective OMN6 Omnix Medical
03-May-2023 CluePoints Supports Launch of RBQM Live 2023 as Premier Event Sponsor CluePoints
03-May-2023 AARDEX Group Partners with Industry Leaders on DiMe’s V3+ Framework Project to Enhance Usability of DHTs AARDEX Group